GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Enterprise Value

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Enterprise Value : $25.44 Mil (As of May. 14, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cannabis Strategic Ventures's Enterprise Value is $25.44 Mil. Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-10.44 Mil. Therefore, Cannabis Strategic Ventures's EV-to-EBIT ratio for today is -2.44.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cannabis Strategic Ventures's Enterprise Value is $25.44 Mil. Cannabis Strategic Ventures's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was $-10.23 Mil. Therefore, Cannabis Strategic Ventures's EV-to-EBITDA ratio for today is -2.49.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cannabis Strategic Ventures's Enterprise Value is $25.44 Mil. Cannabis Strategic Ventures's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $5.74 Mil. Therefore, Cannabis Strategic Ventures's EV-to-Revenue ratio for today is 4.43.


Cannabis Strategic Ventures Enterprise Value Historical Data

The historical data trend for Cannabis Strategic Ventures's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Enterprise Value Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
Enterprise Value
Get a 7-Day Free Trial 1.10 1.43 390.50 197.79 35.48

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.04 79.66 26.94 35.48 42.92

Competitive Comparison of Cannabis Strategic Ventures's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Strategic Ventures's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Enterprise Value falls into.



Cannabis Strategic Ventures Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cannabis Strategic Ventures's Enterprise Value for the fiscal year that ended in Mar. 2020 is calculated as

Cannabis Strategic Ventures's Enterprise Value for the quarter that ended in Jun. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Strategic Ventures  (OTCPK:NUGS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cannabis Strategic Ventures's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=25.441/-10.436
=-2.44

Cannabis Strategic Ventures's current Enterprise Value is $25.44 Mil.
Cannabis Strategic Ventures's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.44 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cannabis Strategic Ventures's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=25.441/-10.232
=-2.49

Cannabis Strategic Ventures's current Enterprise Value is $25.44 Mil.
Cannabis Strategic Ventures's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.23 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cannabis Strategic Ventures's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=25.441/5.74
=4.43

Cannabis Strategic Ventures's current Enterprise Value is $25.44 Mil.
Cannabis Strategic Ventures's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Strategic Ventures Enterprise Value Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000